Effects of polyol excipient stability during storage and use on the quality of biopharmaceutical formulations

Min-Fei Sun; Jia-Ning Liao; Zhen-Yi Jing; Han Gao; Bin-Bin Shen; You-Fu Xu; Wei-Jie Fang

doi:10.1016/j.jpha.2022.03.003

Volume 12 Issue 5

Nov. 2022

Turn off MathJax

Article Contents

Article Navigation > Journal of Pharmaceutical Analysis > 2022 > 12(5): 774-782

Min-Fei Sun, Jia-Ning Liao, Zhen-Yi Jing, Han Gao, Bin-Bin Shen, You-Fu Xu, Wei-Jie Fang. Effects of polyol excipient stability during storage and use on the quality of biopharmaceutical formulations[J]. Journal of Pharmaceutical Analysis, 2022, 12(5): 774-782. doi: 10.1016/j.jpha.2022.03.003

Citation:

Min-Fei Sun, Jia-Ning Liao, Zhen-Yi Jing, Han Gao, Bin-Bin Shen, You-Fu Xu, Wei-Jie Fang. Effects of polyol excipient stability during storage and use on the quality of biopharmaceutical formulations[J]. Journal of Pharmaceutical Analysis, 2022, 12(5): 774-782. doi: 10.1016/j.jpha.2022.03.003

Citation:

Min-Fei Sun, Jia-Ning Liao, Zhen-Yi Jing, Han Gao, Bin-Bin Shen, You-Fu Xu, Wei-Jie Fang. Effects of polyol excipient stability during storage and use on the quality of biopharmaceutical formulations[J]. Journal of Pharmaceutical Analysis, 2022, 12(5): 774-782. doi: 10.1016/j.jpha.2022.03.003

PDF( 1577 KB)

Effects of polyol excipient stability during storage and use on the quality of biopharmaceutical formulations

doi: 10.1016/j.jpha.2022.03.003

a. Institute of Drug Metabolism and Pharmaceutical Analysis, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China;
b. Hangzhou Institute of Innovative Medicine, Zhejiang University, Hangzhou Biopharm Town, Hangzhou, 310016, China;
c. Zhejiang Haisheng Pharmaceutical Inc., Taizhou, Zhejiang, 318000, China

Funds:

Funding for this work was generously provided by the National Natural Science Foundation of China (Grant No.: 81741144) and Ministry of Science and Technology of China (Grant No.: 2018ZX09J18107-002).

Received Date: Sep. 10, 2021
Accepted Date: Mar. 16, 2022
Rev Recd Date: Feb. 19, 2022
Publish Date: Mar. 24, 2022

Abstract

Abstract

Biopharmaceuticals are formulated using a variety of excipients to maintain their storage stability. However, some excipients are prone to degradation during repeated use and/or improper storage, and the impurities generated by their degradation are easily overlooked by end users and are usually not strictly monitored, affecting the stability of biopharmaceuticals. In this study, we evaluated the degradation profile of polyol excipient glycerol during repeated use and improper storage and identified an unprecedented cyclic ketal impurity using gas chromatography with mass spectrometry (GC-MS). The other polyol excipient, mannitol, was much more stable than glycerol. The effects of degraded glycerol and mannitol on the stability of the model biopharmaceutical pentapeptide, thymopentin, were also evaluated. The thymopentin content was only 66.4% in the thymopentin formulations with degraded glycerol, compared to 95.8% in other formulations after the stress test. Most glycerol impurities (i.e., aldehydes and ketones) reacted with thymopentin, affecting the stability of thymopentin formulations. In conclusion, this work suggests that more attention should be paid to the quality changes of excipients during repeated use and storage. Additional testing of excipient stability under real or accelerated conditions by manufacturers would help avoid unexpected and painful results.
- Excipient stability,
- GC-MS,
- Glycerol,
- LC-MS/MS,
- Mannitol,
- Thymopentin

FullText(HTML)

References(55)

References

M.E. Krause, E. Sahin, Chemical and physical instabilities in manufacturing and storage of therapeutic proteins, Curr. Opin. Biotechnol. 60 (2019) 159-167

W.-J. Fang, Y.-Z. Huang, F. Poon, et al., Degradation of biotherapeutics during manufacturing processes and its solution, J. Int. Pharm. Res. 44 (2017) 1012-1018

A.S. Narang, D. Desai, S. Badawy, Impact of excipient interactions on solid dosage form stability, Pharm. Res. 29 (2012) 2660-2683

W. Wang, S. Ohtake, Science and art of protein formulation development, Int. J. Pharm. 568 (2019), 118505

S. Hasan, S. Fatma, M. Zaman, et al., Carboxylic acids of different nature induces aggregation of hemoglobin, Int. J. Biol. Macromol. 118 (2018) 1584-1593

S.Y. Zheng, D.F. Qiu, M. Adams, et al., Investigating the degradation behaviors of a therapeutic monoclonal antibody associated with pH and buffer species, AAPS PharmSciTech. 18 (2017) 42-48

C. Chumsae, L.L. Zhou, Y. Shen, et al., Discovery of a chemical modification by citric acid in a recombinant monoclonal antibody, Anal. Chem. 86 (2014) 8932-8936

S. Ajito, H. Iwase, S.-I. Takata, et al., Sugar-mediated stabilization of protein against chemical or thermal denaturation, J. Phys. Chem. B 122 (2018) 8685-8697

S. James, J.J. McManus, Thermal and solution stability of lysozyme in the presence of sucrose, glucose, and trehalose, J. Phys. Chem. B 116 (2012) 10182-10188

W. Wang, A.A. Ignatius, S.V. Thakkar, Impact of residual impurities and contaminants on protein stability, J. Pharm. Sci. 103 (2014) 1315-1330

L. Zang, T. Carlage, D. Murphy, et al., Residual metals cause variability in methionine oxidation measurements in protein pharmaceuticals using LC-UV/MS peptide mapping, J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 895-896 (2012) 71-76

J.F. Carpenter, S.C. Hand, L.M. Crowe, et al., Cryoprotection of phosphofructokinase with organic solutes: characterization of enhanced protection in the presence of divalent cations, Arch. Biochem. Biophys. 250 (1986) 505-512

W.R. Wasylaschuk, P.A. Harmon, G. Wagner, et al., Evaluation of hydroperoxides in common pharmaceutical excipients, J. Pharm. Sci. 96 (2007) 106-116

H. Santana, Y. González, P.T. Campana, et al., Screening for stability and compatibility conditions of recombinant human epidermal growth factor for parenteral formulation: effect of pH, buffers, and excipients, Int. J. Pharm. 452 (2013) 52-62

V.S. Dave, S.D. Saoji, N.A. Raut, et al., Excipient variability and its impact on dosage form functionality, J. Pharm. Sci. 104 (2015) 906-915

K.C. Waterman, W.B. Arikpo, M.B. Fergione, et al., N-methylation and N-formylation of a secondary amine drug (varenicline) in an osmotic tablet, J. Pharm. Sci. 97 (2008) 1499-1507

G. Wang, J.D. Fiske, S.P. Jennings, et al., Identification and control of a degradation product in Avapro film-coated tablet: low dose formulation, Pharm. Dev. Technol. 13 (2008) 393-399

M.A. Darji, R.M. Lalge, S.P. Marathe, et al., Excipient stability in oral solid dosage forms: A review, AAPS PharmSciTech 19 (2018) 12-26

M. Donbrow, E. Azaz, A. Pillersdorf, Autoxidation of polysorbates, J. Pharm. Sci. 67 (1978) 1676-1681

B.A. Kerwin, Polysorbates 20 and 80 used in the formulation of protein biotherapeutics: structure and degradation pathways, J. Pharm. Sci. 97 (2008) 2924-2935

V.M. Knepp, J.L. Whatley, A. Muchnik, et al., Identification of antioxidants for prevention of peroxide-mediated oxidation of recombinant human ciliary neurotrophic factor and recombinant human nerve growth factor, PDA J. Pharm. Sci. Techol. 50 (1996) 163-171

N. Doshi, R. Fish, K. Padilla, et al., Evaluation of super refined^TM polysorbate 20 with respect to polysorbate degradation, particle formation and protein stability, J. Pharm. Sci. 109 (2020) 2986-2995

A. Tomlinson, B. Demeule, B. Lin, et al., Polysorbate 20 degradation in biopharmaceutical formulations: quantification of free fatty acids, characterization of particulates, and insights into the degradation mechanism, Mol. Pharm. 12 (2015) 3805-3815

M. Saggu, J. Liu, A. Patel, Identification of subvisible particles in biopharmaceutical formulations using Raman spectroscopy provides insight into polysorbate 20 degradation pathway, Pharm. Res. 32 (2015) 2877-2888

M.T. Jones, H.-C. Mahler, S. Yadav, et al., Considerations for the use of polysorbates in biopharmaceuticals, Pharm. Res. 35 (2018), 148

L.C. Becker, W.F. Bergfeld, D.V. Belsito, et al., Safety assessment of glycerin as used in cosmetics, Int. J. Toxicol. 38 (2019) 6S-22S

J. Horn, J. Schanda, W. Friess, Impact of fast and conservative freeze-drying on product quality of protein-mannitol-sucrose-glycerol lyophilizates, Eur. J. Pharm. Biopharm. 127 (2018) 342-354

Y.Z. Tan, Y.Q. Chong, E. Khong, et al., Effect of disaccharide-polyol systems on the thermal stability of freeze-dried Mycobacterium bovis, Int. J. Pharm. 566 (2019) 400-409

B. Katryniok, H. Kimura, E. Skrzyńska, et al., Selective catalytic oxidation of glycerol: perspectives for high value chemicals, Green Chem. 13 (2011) 1960-1979

C.H. Zhou, J.N. Beltramini, Y.X. Fan, et al., Chemoselective catalytic conversion of glycerol as a biorenewable source to valuable commodity chemicals, Chem. Soc. Rev. 37 (2008) 527-549

D.M. Liu, Preparation method of hydroxyacetone by dehydration of glycerol, China patent CN109665952A. 23 April 2019

S.S. Niu, Y.L. Zhu, H.Y. Zheng, et al., Dehydration of glycerol to acetol over copper-based catalysts, Chin. J. Catal. 32 (2011) 345-351

K. Sugiura, S. Koike, T. Suzuki, et al., Oxidative formation of methylglyoxal in glycerol preparations during storage, Biol. Pharm. Bull. 43 (2020) 879-883

Chinese Pharmacopoeia Commission, Pharmacopoeia of People’s Republic of China, 4th Edition, 2015, pp. 490-492

J. Xie, C.-P. Zhang, Y.-M. Wang, Effectiveness of thymopentin as adjuvant therapy: an evidence-based analysis, Chin. J. New Drugs 24 (2015) 2599-2605

L. Jin, G. Wei, W.-y. Lu, Stability of thymopentin solution, Chin. J. Pharm. 38 (2007) 709-711

S. Frokjaer, D.E. Otzen, Protein drug stability: a formulation challenge, Nat. Rev. Drug Discov. 4 (2005) 298-306

European Pharmacopoeia Commission, European Pharmacopoeia, 9th edition, 2017, pp. 2595-2596

T.R. Zhan, J.M. Song, Progress in studies of mannitol in medicinal application, Chin. J. Marine Drugs 3 (2003) 57-61

H. Hibbert, M.S. Whelen, Studies on reactions relating to carbohydrates and polysaccharides. XXIII. Synthesis and properties of hydroxy alkylidene glycols and glycerols, J. Am. Chem. Soc. 51 (1929) 3115-3123

R.F. Fisher, C.W. Smith, inventors; Polyols, United States patent US2888492. 26 May 1959

A.W. Pierpont, E.R. Batista, R.L. Martin, et al., Origins of the regioselectivity in the lutetium triflate catalyzed ketalization of acetone with glycerol: a DFT study, ACS Catal. 5 (2015) 1013-1019

J. McMurry, Organic Compounds: Cycloalkanes and Their Stereochemistry, in: Organic Chemistry, Vol. 4, Brooks/Cole, California, 1999, pp. 121-124

M.A. Casadei, C. Galli, L. Mandolini, Ring-closure reactions. 22. Kinetics of cyclization of diethyl (.omega.-bromoalkyl)malonates in the range of 4- to 21-membered rings. Role of ring strain, J. Am. Chem. Soc. 106 (1984) 1051-1056

G.S. Dmitriev, A.V. Terekhov, L.N. Zanaveskin, et al., Choice of a catalyst and technological scheme for synthesis of solketal, Russ. J. Appl. Chem. 89 (2016) 1619-1624

J. Deutsch, A. Martin, H. Lieske, Investigations on heterogeneously catalysed condensations of glycerol to cyclic acetals, J. Catal. 245 (2007) 428-435

D.K. Chowdhury, H. Sarker, P. Schwartz, Regulatory notes on impact of excipients on drug products and the Maillard reaction, AAPS PharmSciTech. 19 (2018) 965-969

N.E. Robinson, A.B. Robinson, Use of Merrifield solid phase peptide synthesis in investigations of biological deamidation of peptides and proteins, Biopolymers 90 (2008) 297-306

A.A. Wakankar, R.T. Borchardt, Formulation considerations for proteins susceptible to asparagine deamidation and aspartate isomerization, J. Pharm. Sci. 95 (2006) 2321-2336

S. Catak, G. Monard, V. Aviyente, et al., Computational study on nonenzymatic peptide bond cleavage at asparagine and aspartic acid, J. Phys. Chem. A 112 (2008) 8752-8761

E.M. Topp, L. Zhang, H. Zhao, et al., Chemical Instability in Peptide and Protein Pharmceuticals, in: Formulation and Process Development Strategies for Manufacturing Biopharmaceuticals, Vol. 2, John Wiley & Sons, Inc., Hoboken, New Jersey, 2010, pp. 41-67

V.J. Helm, B.W. Müller, Stability of the synthetic pentapeptide thymopentin in aqueous solution: Effect of pH and buffer on degradation, Int. J. Pharm. 70 (1991) 29-34

J. Boonen, L. Veryser, L. Taevernier, et al., Risk evaluation of impurities in topical excipients: the acetol case, J. Pharm. Anal. 4 (2014) 303-315

B. Metz, G.F.A. Kersten, G.J.E. Baart, et al., Identification of formaldehyde-induced modifications in proteins: reactions with insulin, Bioconjugate Chem. 17 (2006) 815-822

B. Li, H. Tang, A. Turlik, et al., Cooperative stapling of native peptides at lysine and tyrosine or arginine with formaldehyde, Angew. Chem. Int. Ed. 60 (2021) 6646-6652

Relative Articles

Supplements(0)

Cited By

Proportional views